When we advise companies on fundraising, it’s about enabling them to achieve their full potential.
We understand that optimising terms is critical, but also finding the right long-term partner for the next phase of growth. So we work with entrepreneurs to help articulate their equity story, target the best investors and negotiate the right deal.
Results recognise that you’re leading a fast-growth business that needs to keep performing well and delivering to the growth plan — and on a practical note, we take a lot of the process work away from you to ensure you have the headspace and time to focus on the business.
Equity Fundraising Deals
BIO International in San Diego: Sunny with scattered economic clouds
The biopharma universe gathered in San Diego last week for the first face to face BIO International conference in three years. Turn-out was good but below the get-together in Philadelphia in 2019. That one topped out above 17,000 attendees according to the BIO website; whisper numbers this time around were in the region of 12,000. I […]
Biotech funding in a risk-off climate – does upstream trouble loom for pharma services providers?
Biotech funding is the key driver of innovation in the pharmaceutical industry and is essential in supporting the healthcare ecosystem. More than 80% of drugs marketed by large pharmaceutical companies were discovered and initially developed by biotechs1. Biotech companies also discovered more than 60% of FDA-approved “priority” drugs, which treat life-threatening conditions and offer significant […]
Crossrail opens – a big day for travellers to and workers in London
At Results Healthcare we execute transactions around the world, with active projects in North America, Europe and Asia Pacific, so we see ourselves as a global organisation with offices and employees in London and New York, so a blog on transport in London might seem oddly parochial, but the opening of Crossrail, or the Elizabeth […]